Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus

ConclusionThis comprehensive analysis confirms that both empagliflozin 10  mg and 25 mg are well tolerated in patients with T2DM, reinforcing the established clinical safety profile of empagliflozin.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research